Figure 11. Validation for the predictive role of risk score on the immunotherapeutic response. (A) Kaplan-Meier survival analysis and distribution of immunotherapy responses of high- and low-score groups in GSE78220. (B) Kaplan-Meier survival analysis and distribution of immunotherapy responses of high- and low-score groups in IMvigor210 dataset. (C) Kaplan-Meier survival analysis and progress risk of high- and low-score groups in the GSE13507 dataset.